158 related articles for article (PubMed ID: 24856302)
1. Synthesis and biological evaluation of substituted 3-anilino-quinolin-2(1H)-ones as PDK1 inhibitors.
O'Brien NJ; Brzozowski M; Wilson DJ; Deady LW; Abbott BM
Bioorg Med Chem; 2014 Jul; 22(14):3781-90. PubMed ID: 24856302
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 2-anilino-4-substituted-7H-pyrrolopyrimidines as PDK1 inhibitors.
O'Brien NJ; Brzozowski M; Buskes MJ; Deady LW; Abbott BM
Bioorg Med Chem; 2014 Aug; 22(15):3879-86. PubMed ID: 25012568
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of potential Rho-kinase inhibitors based on the chemistry of an original heterocycle: 4,4-dimethyl-3,4-dihydro-1H-quinolin-2-one.
Letellier MA; Guillard J; Caignard DH; Ferry G; Boutin JA; Viaud-Massuard MC
Eur J Med Chem; 2008 Aug; 43(8):1730-6. PubMed ID: 18164518
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors.
Han SY; Choi JW; Yang J; Chae CH; Lee J; Jung H; Lee K; Ha JD; Kim HR; Cho SY
Bioorg Med Chem Lett; 2012 Apr; 22(8):2837-42. PubMed ID: 22450128
[TBL] [Abstract][Full Text] [Related]
5. Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors.
McDonnell ME; Bian H; Wrobel J; Smith GR; Liang S; Ma H; Reitz AB
Bioorg Med Chem Lett; 2014 Feb; 24(4):1116-21. PubMed ID: 24461299
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and molecular modelling studies of 4-anilinoquinazoline derivatives as protein kinase inhibitors.
Waiker DK; Karthikeyan C; Poongavanam V; Kongsted J; Lozach O; Meijer L; Trivedi P
Bioorg Med Chem; 2014 Mar; 22(6):1909-15. PubMed ID: 24530227
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of benzoazepin-2-one analogs as allosteric binders targeting the PIF pocket of PDK1.
Wei L; Gao X; Warne R; Hao X; Bussiere D; Gu XJ; Uno T; Liu Y
Bioorg Med Chem Lett; 2010 Jul; 20(13):3897-902. PubMed ID: 20627557
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel N-acyl substituted quinolin-2(1H)-one derivatives as potential antimicrobial agents.
Liu HB; Tang H; Yang D; Deng Q; Yuan LJ; Ji QG
Bioorg Med Chem Lett; 2012 Sep; 22(18):5845-8. PubMed ID: 22902657
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of 2-(3-alkylaminophenyl)-6-(pyrrolidin-1-yl)quinolin-4-ones as potent antitumor agents.
Huang SM; Cheng YY; Chen MH; Huang CH; Huang LJ; Hsu MH; Kuo SC; Lee KH
Bioorg Med Chem Lett; 2013 Feb; 23(3):699-701. PubMed ID: 23260351
[TBL] [Abstract][Full Text] [Related]
10. Novel imidazo[1,2-a]pyridine based inhibitors of the IGF-1 receptor tyrosine kinase: optimization of the aniline.
Ducray R; Jones CD; Jung FH; Simpson I; Curwen J; Pass M
Bioorg Med Chem Lett; 2011 Aug; 21(16):4702-4. PubMed ID: 21764307
[TBL] [Abstract][Full Text] [Related]
11. 4-Anilino-7-alkenylquinoline-3-carbonitriles as potent MEK1 kinase inhibitors.
Berger DM; Dutia M; Powell D; Floyd MB; Torres N; Mallon R; Wojciechowicz D; Kim S; Feldberg L; Collins K; Chaudhary I
Bioorg Med Chem; 2008 Oct; 16(20):9202-11. PubMed ID: 18815050
[TBL] [Abstract][Full Text] [Related]
12. 2-anilino-4-aryl-8H-purine derivatives as inhibitors of PDK1.
Blanchard S; Soh CK; Lee CP; Poulsen A; Bonday Z; Goh KL; Goh KC; Goh MK; Pasha MK; Wang H; Williams M; Wood JM; Ethirajulu K; Dymock BW
Bioorg Med Chem Lett; 2012 Apr; 22(8):2880-4. PubMed ID: 22437109
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 5-substituted-1H-indol-2-yl-1H-quinolin-2-ones: a novel class of KDR kinase inhibitors.
Kuethe JT; Wong A; Qu C; Smitrovich J; Davies IW; Hughes DL
J Org Chem; 2005 Apr; 70(7):2555-67. PubMed ID: 15787543
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, screening and docking analysis of 4-anilinoquinazoline derivatives as tyrosine kinase inhibitors.
Lü S; Zheng W; Ji L; Luo Q; Hao X; Li X; Wang F
Eur J Med Chem; 2013 Mar; 61():84-94. PubMed ID: 22867529
[TBL] [Abstract][Full Text] [Related]
15. Implications for selectivity of 3,4-diarylquinolinones as p38alphaMAP kinase inhibitors.
Peifer C; Urich R; Schattel V; Abadleh M; Röttig M; Kohlbacher O; Laufer S
Bioorg Med Chem Lett; 2008 Feb; 18(4):1431-5. PubMed ID: 18207396
[TBL] [Abstract][Full Text] [Related]
16. DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotype.
Cano C; Barbeau OR; Bailey C; Cockcroft XL; Curtin NJ; Duggan H; Frigerio M; Golding BT; Hardcastle IR; Hummersone MG; Knights C; Menear KA; Newell DR; Richardson CJ; Smith GC; Spittle B; Griffin RJ
J Med Chem; 2010 Dec; 53(24):8498-507. PubMed ID: 21080722
[TBL] [Abstract][Full Text] [Related]
17. 4-Anilino-6-phenyl-quinoline inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK2).
Olsson H; Sjö P; Ersoy O; Kristoffersson A; Larsson J; Nordén B
Bioorg Med Chem Lett; 2010 Aug; 20(16):4738-40. PubMed ID: 20643547
[TBL] [Abstract][Full Text] [Related]
18. Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: design, synthesis and biological activity.
Islam I; Bryant J; Chou YL; Kochanny MJ; Lee W; Phillips GB; Yu H; Adler M; Whitlow M; Ho E; Lentz D; Polokoff MA; Subramanyam B; Wu JM; Zhu D; Feldman RI; Arnaiz DO
Bioorg Med Chem Lett; 2007 Jul; 17(14):3814-8. PubMed ID: 17531483
[TBL] [Abstract][Full Text] [Related]
19. 4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors.
Zhang N; Wu B; Boschelli DH; Golas JM; Boschelli F
Bioorg Med Chem Lett; 2009 Sep; 19(17):5071-4. PubMed ID: 19632113
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and SAR of 1,9-dihydro-9-hydroxypyrazolo[3,4-b]quinolin-4-ones as novel, selective c-Jun N-terminal kinase inhibitors.
Liu M; Xin Z; Clampit JE; Wang S; Gum RJ; Haasch DL; Trevillyan JM; Abad-Zapatero C; Fry EH; Sham HL; Liu G
Bioorg Med Chem Lett; 2006 May; 16(10):2590-4. PubMed ID: 16527482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
